Multidrug-resistant candida haemulonii and C. Auris, tel aviv, Israel

Emerging Infectious Diseases

Volumn 23, Issue 2, 2017, Pages 195-203

  Ben Ami, Ronen ^a,b   Berman, Judith ^a   Novikov, Ana ^b   Bash, Edna ^b   Shachor Meyouhas, Yael ^c   Zakin, Shiri ^a   Maor, Yasmin ^a,d   Tarabia, Jalal ^b   Schechner, Vered ^a,b   Adler, Amos ^a,b   Finn, Talya ^b  

^a TEL AVIV UNIVERSITY   (Israel)

^b TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^c Ruth Rappaport Children's Hospital   (Israel)

^d WOLFSON MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANIDULAFUNGIN; CASPOFUNGIN; FLUCONAZOLE; FLUCYTOSINE; INTERNAL TRANSCRIBED SPACER; ITRACONAZOLE; MICAFUNGIN; POSACONAZOLE; RHODAMINE 6G; VORICONAZOLE; ANTIFUNGAL AGENT;

ANIMAL MODEL; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; CANDIDA; HEAT TOLERANCE; HISTOLOGY; ISRAEL; MULTIDRUG RESISTANCE; NONHUMAN; PHENOTYPE; PHYLOGENY; POLYMERASE CHAIN REACTION; RISK FACTOR; ADULT; AGED; BLOOD; CANDIDIASIS; CLINICAL TRIAL; DRUG EFFECTS; FEMALE; GENETICS; HUMAN; ISOLATION AND PURIFICATION; MALE; MICROBIAL SENSITIVITY TEST; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MIDDLE AGED; MULTICENTER STUDY; RETROSPECTIVE STUDY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTIFUNGAL AGENTS; CANDIDA; CANDIDIASIS; DRUG RESISTANCE, MULTIPLE, FUNGAL; FEMALE; HUMANS; ISRAEL; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MYCOLOGICAL TYPING TECHNIQUES; RETROSPECTIVE STUDIES;

EID: 85009957625     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid2302.161486     Document Type: Article

References (33)

1. Magill SS, Edwards JR, Bamberg W, Beldavs ZG, Dumyati G, Kainer MA, et al.; Emerging Infections Program Healthcare-Associated Infections and Antimicrobial Use Prevalence Survey Team. Multistate point-prevalence survey of health care-associated infections. N Engl J Med. 2014;370:1198-208. http://dx.doi.org/10.1056/NEJMoa1306801
2. Kullberg BJ, Arendrup MC. Invasive candidiasis. N Engl J Med. 2015;373:1445-56. http://dx.doi.org/10.1056/NEJMra1315399
3. Garey KW, Rege M, Pai MP, Mingo DE, Suda KJ, Turpin RS, et al. Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study. Clin Infect Dis. 2006;43:25-31. http://dx.doi.org/10.1086/504810
4. Andes DR, Safdar N, Baddley JW, Playford G, Reboli AC, Rex JH, et al.; Mycoses Study Group. Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive candidiasis: a patient-level quantitative review of randomized trials. Clin Infect Dis. 2012;54:1110-22. http://dx.doi.org/10.1093/cid/cis021
5. Alexander BD, Johnson MD, Pfeiffer CD, Jiménez-Ortigosa C, Catania J, Booker R, et al. Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations. Clin Infect Dis. 2013;56:1724-32. http://dx.doi.org/10.1093/cid/cit136
6. Satoh K, Makimura K, Hasumi Y, Nishiyama Y, Uchida K, Yamaguchi H. Candida auris sp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital. Microbiol Immunol. 2009;53:41-4. http://dx.doi.org/10.1111/j.1348-0421.2008.00083.x
7. Lee WG, Shin JH, Uh Y, Kang MG, Kim SH, Park KH, et al. First three reported cases of nosocomial fungemia caused by Candida auris. J Clin Microbiol. 2011;49:3139-42. http://dx.doi.org/10.1128/JCM.00319-11
8. Chowdhary A, Sharma C, Duggal S, Agarwal K, Prakash A, Singh PK, et al. New clonal strain of Candida auris, Delhi, India. Emerg Infect Dis. 2013;19:1670-3. http://dx.doi.org/10.3201/eid1910.130393
9. Magobo RE, Corcoran C, Seetharam S, Govender NP. Candida auris-associated candidemia, South Africa. Emerg Infect Dis. 2014;20:1250-1. http://dx.doi.org/10.3201/eid2007.131765
10. Chowdhary A, Anil Kumar V, Sharma C, Prakash A, Agarwal K, Babu R, et al. Multidrug-resistant endemic clonal strain of Candida auris in India. Eur J Clin Microbiol Infect Dis. 2014;33:919-26. http://dx.doi.org/10.1007/s10096-013-2027-1
11. Okinda N, Kagotho E, Castanheira M, Njuguna A, Omuse G, Makau P, et al. Candidemia at a referral hospital in sub-Saharan Africa: emergence of Candida auris as a major pathogen. European Conference on Clinical Microbiology and Infectious Diseases; 2014 May 10-13; Barcelona, Spain.
12. Centers for Disease Control and Prevention. Global emergence of invasive infections caused by the multidrug-resistant yeast Candida auris [cited 2016 Jul 29]. http://www.cdc.gov/fungal/diseases/candidiasis/candida-auris-alert.html
13. Public Health England. Candida auris identified in England [cited 2016 Jul 1]. https://www.gov.uk/government/publications/candida-auris-emergence-in-england/candida-auris-identified-in-england
14. Schoch CL, Seifert KA, Huhndorf S, Robert V, Spouge JL, Levesque CA, et al.; Fungal Barcoding Consortium. Nuclear ribosomal internal transcribed spacer (ITS) region as a universal DNA barcode marker for fungi. Proc Natl Acad Sci U S A. 2012;109:6241-6. http://dx.doi.org/10.1073/pnas.1117018109
15. Edgar RC. MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res. 2004;32:1792-7. http://dx.doi.org/10.1093/nar/gkh340
16. Saitou N, Nei M. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol. 1987;4:406-25.
17. Kimura M. A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences. J Mol Evol. 1980;16:111-20. http://dx.doi.org/10.1007/BF01731581
18. Kumar S, Stecher G, Tamura K. MEGA7: Molecular Evolutionary Genetics Analysis version 7.0 for bigger datasets. Mol Biol Evol. 2016;33:1870-4. http://dx.doi.org/10.1093/molbev/msw054
19. Clinical and Laboratory Standards Institute. Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard M27-A3. Wayne (PA): The Institute; 2008.
20. Maesaki S, Marichal P, Vanden Bossche H, Sanglard D, Kohno S. Rhodamine 6G efflux for the detection of CDR1-overexpressing azole-resistant Candida albicans strains. J Antimicrob Chemother. 1999;44:27-31. http://dx.doi.org/10.1093/jac/44.1.27
21. Kolaczkowski M, van der Rest M, Cybularz-Kolaczkowska A, Soumillion JP, Konings WN, Goffeau A. Anticancer drugs, ionophoric peptides, and steroids as substrates of the yeast multidrug transporter Pdr5p. J Biol Chem. 1996;271:31543-8. http://dx.doi.org/10.1074/jbc.271.49.31543
22. Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, Hendriksen S, et al.; Chronic Kidney Disease Epidemiology Collaboration. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med. 2006;145:247-54. http://dx.doi.org/10.7326/0003-4819-145-4-200608150-00004
23. Pfaller MA, Espinel-Ingroff A, Canton E, Castanheira M, Cuenca-Estrella M, Diekema DJ, et al. Wild-type MIC distributions and epidemiological cutoff values for amphotericin B, flucytosine, and itraconazole and Candida spp. as determined by CLSI broth microdilution. J Clin Microbiol. 2012;50:2040-6. http://dx.doi.org/10.1128/JCM.00248-12
24. Park BJ, Arthington-Skaggs BA, Hajjeh RA, Iqbal N, Ciblak MA, Lee-Yang W, et al. Evaluation of amphotericin B interpretive breakpoints for Candida bloodstream isolates by correlation with therapeutic outcome. Antimicrob Agents Chemother. 2006; 50:1287-92. http://dx.doi.org/10.1128/AAC.50.4.1287-1292.2006
25. Chatterjee S, Alampalli SV, Nageshan RK, Chettiar ST, Joshi S, Tatu US. Draft genome of a commonly misdiagnosed multidrug resistant pathogen Candida auris. BMC Genomics. 2015;16:686. http://dx.doi.org/10.1186/s12864-015-1863-z
26. Public Health England. Guidance for the laboratory investigation, management and infection prevention and control for cases of Candida auris [cited 2016 Jul 1]. https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/534174/Guidance:Candida__auris.pdf
27. de Almeida JN Jr, Assy JG, Levin AS, Del Negro GM, Giudice MC, Tringoni MP, et al. Candida haemulonii complex species, Brazil, January 2010-March 2015. Emerg Infect Dis. 2016;22:561-3. http://dx.doi.org/10.3201/eid2203.151610
28. Kumar A, Prakash A, Singh A, Kumar H, Hagen F, Meis JF, et al. Candida haemulonii species complex: an emerging species in India and its genetic diversity assessed with multilocus sequence and amplified fragment-length polymorphism analyses. Emerg Microbes Infect. 2016;5:e49. http://dx.doi.org/10.1038/emi.2016.49
29. Kim MN, Shin JH, Sung H, Lee K, Kim EC, Ryoo N, et al. Candida haemulonii and closely related species at 5 university hospitals in Korea: identification, antifungal susceptibility, and clinical features. Clin Infect Dis. 2009;48:e57-61. http://dx.doi.org/10.1086/597108
30. Ramos LS, Figueiredo-Carvalho MH, Barbedo LS, Ziccardi M, Chaves AL, Zancopé-Oliveira RM, et al. Candida haemulonii complex: species identification and antifungal susceptibility profiles of clinical isolates from Brazil. J Antimicrob Chemother. 2015;70:111-5. http://dx.doi.org/10.1093/jac/dku321
31. Ruan SY, Kuo YW, Huang CT, Hsiue HC, Hsueh PR. Infections due to Candida haemulonii: species identification, antifungal susceptibility and outcomes. Int J Antimicrob Agents. 2010;35:85-8. http://dx.doi.org/10.1016/j.ijantimicag.2009.08.009
32. Khan ZU, Al-Sweih NA, Ahmad S, Al-Kazemi N, Khan S, Joseph L, et al. Outbreak of fungemia among neonates caused by Candida haemulonii resistant to amphotericin B, itraconazole, and fluconazole. J Clin Microbiol. 2007;45:2025-7. http://dx.doi.org/10.1128/JCM.00222-07
33. Borman AM, Szekely A, Johnson EM, Mitchell AP. Comparative pathogenicity of United Kingdom isolates of the emerging pathogen Candida auris and other key pathogenic Candida species. mSphere. 2016;1.pii:e00189-16.